Form 4: Alkermes SVP Nichols Reports Share Transactions
Insider Transaction Report
Alkermes plc's SVP, Chief Commercial Officer, Christian Todd Nichols, reported the vesting of restricted stock units and subsequent sale of shares for tax purposes.
Summary
- Christian Todd Nichols, SVP, Chief Commercial Officer of Alkermes plc, reported transactions involving the company's ordinary shares.
- On February 26, 2026, 5,410 ordinary shares were acquired through the vesting of a restricted stock unit (RSU) award.
- Following the RSU vesting, 2,403 ordinary shares were disposed of on February 26, 2026, at a price of $30.73 per share, typically for tax withholding purposes.
- After these transactions, Christian Todd Nichols directly beneficially owns 115,769 ordinary shares.
- Additionally, 10,819 derivative restricted stock units remain beneficially owned.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this filing as neutral. It reports routine insider transactions related to compensation, which do not typically indicate a change in the company's fundamental outlook or performance.
Positives
- The vesting of 5,410 restricted stock units represents a realization of compensation for the SVP, Chief Commercial Officer.
Negatives
- A disposition of 2,403 ordinary shares occurred, reducing the direct beneficial ownership of the reporting person.
Future Outlook
The restricted stock unit award vests in four equal annual installments, commencing on February 26, 2025, indicating future scheduled share acquisitions for the reporting person.
Industry Context
StockSavvy.ai notes that Form 4 filings are standard regulatory disclosures for insiders, detailing changes in their beneficial ownership. These transactions, often related to pre-scheduled compensation plans like RSU vesting and subsequent tax-related sales, are common across the pharmaceutical and biotechnology sectors.
Stakeholder Impact
- Shareholders: The disposition of shares by an officer, even for tax purposes, slightly reduces insider ownership, but is a common occurrence and generally not a significant concern for long-term investors.
- Employees: The vesting of RSUs demonstrates the company's compensation structure for its executives.
Next Steps
- Future vesting events for the remaining restricted stock units are scheduled to occur in equal annual installments, commencing on February 26, 2025.
Key Dates
| Date | Description |
|---|---|
| 02/26/2025 | Commencement date for the vesting of restricted stock unit awards in four equal annual installments. |
| 02/26/2026 | Transaction date for the acquisition of ordinary shares due to RSU vesting and the disposition of ordinary shares for tax purposes. |
| 02/27/2026 | Signature date of the Form 4 filing. |
Recommendation
holdThis Form 4 filing details routine insider transactions related to compensation (RSU vesting and tax-related sales). It does not provide new material information regarding the company's operational performance, strategic direction, or financial health that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate as there is no new fundamental catalyst.
Keywords
Alkermes, ALKS, Insider Transaction, Form 4, Restricted Stock Unit, RSU, Share Vesting, Officer Compensation, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.